Showing results (1-10 of 187) with videos related to
Sort By:
Pageof 19
Bulletin Du Cancer|July 24, 2002
[Standards, options and recommendations for the management of prostate cancer: therapeutic decision criteria]Pierre Pabot Du Chatelard, Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|March 22, 2005
[Spinal cord metastasis from prostate cancer]Khadija Jalali, Denis Chautard, Pierre Racineux, et al.Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|August 23, 2002
[Biochemical monitoring of prostate cancer treated exclusively by radiotherapy: prognostic value of pretreatment PSA, PSA nadir and PSA half-life]Denis Chautard, Patrice Cellier, Isabelle Dalifard, et al.Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|April 22, 2003
[Erectile dysfunction: knowledge, wishes and attitudes. Results of a French study of 5.099 men aged 17 to 70]Pierre Costa, Christophe Avances, Laurent WagnerEuropean Urology Focus|July 21, 2017
Metastatic Castration-resistant Prostate Cancer: Major Progress Leading to Even More QuestionsNicolas MottetCurrent Opinion in Urology|May 14, 2013
Results of hormone therapy as first-line treatment for high-risk prostate cancerNicolas MottetProgres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|January 28, 2003
[Non-typhus Salmonella urinary tract infections]Stéphane Viale, Christophe Avances, Kamel Bennaoum, et al.Bulletin Du Cancer|December 29, 2019
[Management of residual masses of testis germ cell tumors]Lancelot Tremeau, Nicolas MottetDrugs & Aging|August 25, 2022
Management of Biochemical Recurrence of Prostate Cancer After Curative Treatment: A Focus on Older PatientsLancelot Tremeau, Nicolas MottetOncology Research and Treatment|December 4, 2015
Androgen Deprivation Therapy in Prostate Cancer - Current Status in M1 PatientsHocine Habchi, Nicolas MottetPageof 19